Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Harnessing cholesterol uptake of malaria parasites for therapeutic applications.
Fraser M, Curtis B, Phillips P, Yates PA, Lam KS, Netzel O, van Dooren GG, Ingmundson A, Matuschewski K, McLeod MD, Maier AG. Fraser M, et al. Among authors: yates pa. EMBO Mol Med. 2024 Jul;16(7):1515-1532. doi: 10.1038/s44321-024-00087-1. Epub 2024 Jun 11. EMBO Mol Med. 2024. PMID: 38862600 Free PMC article.
Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD.
Logan B, Pascoe EM, Viecelli AK, Johnson DW, Comans T, Hawley CM, Hickey LE, Janda M, Jaure A, Kalaw E, Kiriwandeniya C, Matsuyama M, Mihala G, Nguyen KH, Pole JD, Polkinghorne KR, Pond D, Raj R, Reidlinger DM, Scholes-Robertson N, Valks A, Wong G, Hubbard RE; GOAL Trial Investigators. Logan B, et al. Kidney Int Rep. 2024 Oct 15;10(1):120-133. doi: 10.1016/j.ekir.2024.10.009. eCollection 2025 Jan. Kidney Int Rep. 2024. PMID: 39810773 Free PMC article.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Vulnerability to environmental and climatic health provocations among women and men hospitalized with chronic heart disease: insights from the RESILIENCE TRIAL cohort.
Stewart S, Patel SK, Lancefield TF, Rodrigues TS, Doumtsis N, Jess A, Vaughan-Fowler ER, Chan YK, Ramchand J, Yates PA, Kwong JC, McDonald CF, Burrell LM. Stewart S, et al. Among authors: yates pa. Eur J Cardiovasc Nurs. 2024 Apr 12;23(3):278-286. doi: 10.1093/eurjcn/zvad076. Eur J Cardiovasc Nurs. 2024. PMID: 37625011 Clinical Trial.
Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals-a cluster randomised controlled trial.
Logan B, Viecelli AK, Johnson DW, Aquino EM, Bailey J, Comans TA, Gray LC, Hawley CM, Hickey LE, Janda M, Jaure A, Jose MD, Kalaw E, Kiriwandeniya C, Matsuyama M, Mihala G, Nguyen KH, Pascoe E, Pole JD, Polkinghorne KR, Pond D, Raj R, Reidlinger DM, Scholes-Robertson N, Varghese J, Wong G, Hubbard RE; GOAL Trial Investigators. Logan B, et al. Trials. 2023 May 30;24(1):365. doi: 10.1186/s13063-023-07363-4. Trials. 2023. PMID: 37254217 Free PMC article.
Optimization of Orally Bioavailable Antileishmanial 2,4,5-Trisubstituted Benzamides.
Kim HS, Ortiz D, Kadayat TM, Fargo CM, Hammill JT, Chen Y, Rice AL, Begley KL, Shoeran G, Pistel W, Yates PA, Sanchez MA, Landfear SM, Guy RK. Kim HS, et al. Among authors: yates pa. J Med Chem. 2023 Jun 8;66(11):7374-7386. doi: 10.1021/acs.jmedchem.3c00056. Epub 2023 May 22. J Med Chem. 2023. PMID: 37216489 Free PMC article.
80 results